Basic Information
OmniaBio, a subsidiary of CCRM based in Toronto, is a contract development and manufacturing organization (CDMO) that produces gene-modified cell therapies and viral vectors. OmniaBio will support various cell and gene therapy companies from Canada and internationally, leveraging the global demand for cell and gene therapy manufacturing, which outstrips supply by at least five times.